Literature DB >> 16392623

Cortisol levels during an oral glucose tolerance test in lean and obese women.

Mehtap Cakir1, Ramazan Sari, Ozgur Tosun, Umit Karayalcin.   

Abstract

Because of the similarities between Cushing's syndrome and insulin resistance syndrome,cortisol metabolism in obesity has been investigated in numerous studies. Our study investigates serum glucose, insulin, and cortisol response to oral glucose stimulation in a group of obese and lean normotensive, normolipidemic, and glucose-tolerant premenopausal women. Twenty-one obese [body mass index (BMI) 37Z +/- 6.3 kg/m2) and 14 lean (BMI: 21.5 +/- 1.0 kg/m2) age-matched healthy premenopausal women were included in the study. Serum glucose, insulin, and cortisol levels were measured at 30-minute intervals during 120 minutes of oral glucose tolerance testing (OGTT). Mean serum glucose and insulin levels were significantly higher in the obese group compared with lean subjects, and cortisol levels were similar during OGTT. There was not a significant difference for cortisol area under the curve (AUC) during OGTT between the two groups. No correlation between cortisol AUC, insulin AUC, and glucose AUC was noted for both groups. During OGTT, a decrease in cortisol levels was observed in both groups. The decrement occurred at 30 minutes of the OGTT in the obese group and at 60 minutes of the OGTT in the lean group. At 90 and 120 minutes of the OGTT, serum cortisol levels were similar to basal levels in both the obese group and the lean group. Previous studies reported altered hypotalamic-pituitary-adrenal axis activity, altered levels of urinary cortisol excretion, and increased metabolic clearance of cortisol in obesity. In our study in obese women, the only detected difference from lean subjects was a quicker suppression and recovery in serum cortisol levels after glucose administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16392623     DOI: 10.1080/07435800500373199

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  6 in total

1.  Obesity and the hypothalamic-pituitary-adrenal axis in adolescent girls.

Authors:  Jennifer B Hillman; Lorah D Dorn; Tammy L Loucks; Sarah L Berga
Journal:  Metabolism       Date:  2011-09-23       Impact factor: 8.694

2.  The Association between Dietary Patterns and Pre-Pregnancy BMI with Gestational Weight Gain: The "Born in Shenyang" Cohort.

Authors:  Jiajin Hu; Ming Gao; Yanan Ma; Ningyu Wan; Yilin Liu; Borui Liu; Lin Li; Yang Yu; Yang Liu; Bohan Liu; Deliang Wen
Journal:  Nutrients       Date:  2022-06-20       Impact factor: 6.706

3.  Changes in appetite during quarantine and their association with pre-COVID-19 mental and physical health.

Authors:  Diana V Rodriguez-Moreno; Sima Vazquez; Keely Cheslack-Postava; Guangling Xu; Yael M Cycowicz
Journal:  Appetite       Date:  2022-06-03       Impact factor: 5.016

4.  Response of multiple hormones to glucose and arginine challenge in T2DM after gastric bypass.

Authors:  Giovanni Fanni; Petros Katsogiannos; Bipasha Nandi Jui; Magnus Sundbom; Susanne Hetty; Maria J Pereira; Jan W Eriksson
Journal:  Endocr Connect       Date:  2022-07-25       Impact factor: 3.221

5.  Modulation in Wistar rats of blood corticosterone compartmentation by sex and a cafeteria diet.

Authors:  María del Mar Romero; Fredrik Holmgren-Holm; Maria del Mar Grasa; Montserrat Esteve; Xavier Remesar; José Antonio Fernández-López; Marià Alemany
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

6.  α-Melanocyte stimulating hormone promotes muscle glucose uptake via melanocortin 5 receptors.

Authors:  Pablo J Enriori; Weiyi Chen; Maria C Garcia-Rudaz; Bernadette E Grayson; Anne E Evans; Sarah M Comstock; Ursel Gebhardt; Hermann L Müller; Thomas Reinehr; Belinda A Henry; Russell D Brown; Clinton R Bruce; Stephanie E Simonds; Sara A Litwak; Sean L McGee; Serge Luquet; Sarah Martinez; Martin Jastroch; Matthias H Tschöp; Matthew J Watt; Iain J Clarke; Christian L Roth; Kevin L Grove; Michael A Cowley
Journal:  Mol Metab       Date:  2016-08-05       Impact factor: 7.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.